<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>About - i-CLASSi Tool</title>
    <link rel="stylesheet" href="styles.css">
</head>
<body class="gradient-bg about-page">

    <!-- Navigation Bar -->
    <header>
        <nav>
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="ihc.html">i-CLASSi</a></li>
                <li><a href="mapping.html">Mapping</a></li>
                <li><a href="i-riskdb.html">i-Riskdb</a></li>
                <li><a href="i-gwasdb.html">i-GWASdb</a></li>
                <li><a href="abbreviations.html">Abbreviations</a></li>
                <li><a href="about.html">About</a></li>
            </ul>
        </nav>
    </header>

    <!-- Main content section -->
    <section class="main about-page">
        <div class="content">
            <h1>About the i-CLASSi Tool</h1>

            <p><strong>Disclaimer:</strong> This tool is developed for research and educational purposes only. 
            It is not intended for clinical diagnosis or treatment guidance.</p>

            <h2>Overview</h2>
            <p>The InterLymph Consortium (International Consortium of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies) 
               is an open scientific forum for epidemiologic research in non-Hodgkin's lymphoma. Formed in 2001, the Consortium is a group of 
               international investigators who collaborate on case–control studies and pooled data analyses, advancing lymphoma epidemiology 
               through standardized classification and collaborative research.</p>

            <p>Learn more at the <a href="https://epi.grants.cancer.gov/interlymph/" target="_blank">InterLymph website</a>.</p>

            <h2>Pathology Working Group</h2>
            <p>The InterLymph Pathology Working Group includes hematopathologists, epidemiologists, and researchers committed to harmonizing 
               lymphoma disease classification for epidemiologic studies.</p>

            <h2>Citation</h2>
            <ol>
                <li>Turner, J. J., et al. (2010). InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. <i>Blood</i>, 116(20), e90–e98.</li>
                <li>Morton, L. M., et al. (2007). Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of InterLymph. <i>Blood</i>, 110(2), 695–708.</li>
                <li>Pathology Working Group (2024). InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2022): update and future directions. <i>LN Journal</i>.</li>
            </ol>

            <h2>Data Sources</h2>
            <ul>
                <li><strong>ICD-O-3</strong> – International Classification of Diseases for Oncology, 3rd Edition (WHO)</li>
                <li><strong>ICD-9</strong> – International Classification of Diseases, Ninth Revision (WHO/CDC)</li>
                <li><strong>ICD-10</strong> – International Classification of Diseases, Tenth Revision (WHO)</li>
                <li><strong>ICD-10-CM</strong> – ICD-10 Clinical Modification (U.S. National Center for Health Statistics, CDC)</li>
                <li><strong>ICD-11</strong> – International Classification of Diseases, Eleventh Revision (WHO)</li>
                <li><strong>SNOMED CT</strong> – Systematized Nomenclature of Medicine Clinical Terms (© IHTSDO)</li>
                <li><strong>NCIt</strong> – NCI Thesaurus, National Cancer Institute</li>
                <li><strong>EFO</strong> – Experimental Factor Ontology (EMBL-EBI, licensed under CC BY 4.0)</li>
                <li><strong>UMLS CUI</strong> – Unified Medical Language System, Concept Unique Identifiers (U.S. National Library of Medicine)</li>
            </ul>

            <h2>Copyright and Licensing</h2>
            <p>This tool integrates content from multiple biomedical classification and ontology systems. All data remain the intellectual property of their respective organizations:</p>
            <ul>
                <li>© World Health Organization (WHO): ICD-O-3, ICD-9, ICD-10, ICD-11.</li>
                <li>© U.S. Centers for Disease Control and Prevention (CDC): ICD-10-CM.</li>
                <li>© International Health Terminology Standards Development Organisation (IHTSDO): SNOMED CT.</li>
                <li>© National Cancer Institute: NCI Thesaurus.</li>
                <li>© U.S. National Library of Medicine: UMLS.</li>
                <li>© EMBL-EBI: EFO (licensed under CC BY 4.0).</li>
            </ul>
            <p>All content is used under fair use and for research/educational purposes only. This tool is not intended for clinical decision-making.</p>

            <h2>Team and Contributors</h2>

            <h3>Webtool Development</h3>
            <ul>
                <li><strong>Murat Güler</strong> (Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany, <a href="mailto:murat.guler@dkfz.de">murat.guler@dkfz.de</a>)</li>
                <li><strong>Federico Canzian</strong> (Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany)</li>
            </ul>

            <h3>Classification Contributors</h3>
            <ol>
                <li><strong>Alyssa Clay-Gilmour</strong> (Department of Epidemiology &amp; Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA)</li>
                <li><strong>Murat Güler</strong> (Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany)</li>
                <li><strong>James R. Cerhan</strong> (Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA)</li>
                <li><strong>Karin E. Smedby</strong> (Dept of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, and Dept of Hematology, Karolinska University Hospital, Stockholm, Sweden)</li>
                <li><strong>Arjan Diepstra</strong> (Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands)</li>
                <li><strong>InterLymph Consortium Pathology and Survival Working Group</strong></li>
            </ol>

            <h2>Updates</h2>
            <ul>
                <li>10/01/2024 – WHO 2022 classification incorporated</li>
                <li>06/22/2010 – InterLymph update</li>
                <li>05/15/2008 – Initial InterLymph classification</li>
            </ul>
        </div>
    </section>

    <footer>
        <div class="footer-content">
            <p>&copy; 2024 M Guler. All rights reserved.</p>
            <nav>
                <ul>
                    <li><a href="index.html">Home</a></li>
                    <li><a href="ihc.html">i-CLASSi</a></li>
                    <li><a href="mapping.html">Mapping</a></li>
                    <li><a href="i-riskdb.html">i-Riskdb</a></li>
                    <li><a href="i-gwasdb.html">i-GWASdb</a></li>
                    <li><a href="abbreviations.html">Abbreviations</a></li>
                    <li><a href="about.html">About</a></li>
                </ul>
            </nav>
        </div>
    </footer>

</body>
</html>
